Eisai Wins Injunction In Aricept Case
A federal judge has granted Eisai Co. Ltd.'s request for a preliminary injunction to block Teva Pharmaceutical Industries Ltd. from marketing a generic version of its Alzheimer's disease treatment Aricept....To view the full article, register now.
Already a subscriber? Click here to view full article